Kiniksa Pharmaceuticals (KNSA) Insider Trading & Ownership

$17.88
+0.27 (+1.53%)
(As of 04/26/2024 ET)

Kiniksa Pharmaceuticals (NASDAQ:KNSA) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
54.23%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$2.51 M
Get KNSA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Kiniksa Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

KNSA Insider Buying and Selling by Quarter

Kiniksa Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/6/2024Sanj K PatelCEOSell5,582$21.00$117,222.00  
3/4/2024Sanj K PatelCEOSell12,742$21.49$273,825.58  
3/1/2024Michael R MegnaCAOSell9,659$21.45$207,185.55  
2/28/2024Michael R MegnaCAOSell5,126$21.79$111,695.54  
1/3/2024Mark RagosaCFOSell12,000$20.00$240,000.00  
1/2/2024Michael R MegnaCAOSell16,670$19.17$319,563.90  
12/19/2023Michael R MegnaCAOSell9,316$19.13$178,215.08  
12/7/2023John F PaoliniInsiderSell28,600$17.65$504,790.00  
9/5/2023John F PaoliniInsiderSell400$17.53$7,012.00  
7/25/2023John F PaoliniInsiderSell29,000$19.14$555,060.00  
(Data available from 1/1/2013 forward)

KNSA Insider Trading Activity - Frequently Asked Questions

Who is on Kiniksa Pharmaceuticals's Insider Roster?

The list of insiders at Kiniksa Pharmaceuticals includes Barry D. Quart, John F Paolini, Mark Ragosa, Michael R Megna, and Sanj K Patel. Learn more on insiders at KNSA.

What percentage of Kiniksa Pharmaceuticals stock is owned by insiders?

54.23% of Kiniksa Pharmaceuticals stock is owned by insiders. Learn more on KNSA's insider holdings.

Which Kiniksa Pharmaceuticals insiders have been selling company stock?

The following insiders have sold KNSA shares in the last 24 months: Barry D. Quart ($354,637.85), John F Paolini ($1,066,862.00), Mark Ragosa ($240,000.00), Michael R Megna ($816,660.07), and Sanj K Patel ($391,047.58).

How much insider selling is happening at Kiniksa Pharmaceuticals?

Insiders have sold a total of 151,054 Kiniksa Pharmaceuticals shares in the last 24 months for a total of $2,869,207.50 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:KNSA) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners